ReviewInnovation in aging2025
Cost-benefit analysis of interventions for dementia: a scoping review.
Review in Innovation in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Recently, cost-benefit analysis has been increasingly used to evaluate the value of interventions for dementia. This study aims to synthesize the methodology used in cost-benefit analysis (CBA) for dementia interventions. Research Design and Methods: We conducted a scoping review with comprehensive systematic searches for original peer-reviewed articles published from January 2010 to December 2023, and included the studies if they (1) performed a CBA of interventions for dementia, (2) described either cost or benefit items, and (3) performed quantitative data analysis on either costs or benefits. The review adhered to the PRISMA Extension for Scoping Reviews Checklist to write the report. Results: Of the 3415 articles found from the search, 15 were included in the review. Data analysis included the traditional CBA approach and its integration with the social return on investment approach. The set of cost and benefit items may vary depending on the intervention. Staff training, intervention supplies, building hire, and transportation were common cost items. Quality-adjusted life years (QALY), general practitioner visits, and emergency room visits were common benefit items. Cost data were often sourced from the study budget/assumptions. Benefit data were often sourced from the social value banks and literature. Market and shadow pricing were used for cost valuation. The value of statistical life was frequently used for benefit valuation. Discussion and Implications: This review synthesized data analysis methods, lists of cost and benefit items, data sources, and valuation methods used in the CBA of interventions for dementia. The findings provide helpful information for considering methodology in future CBA of interventions for dementia and similar interventions or conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.